Stay updated on REGN 2810 vs Platinum Chemo in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the REGN 2810 vs Platinum Chemo in Metastatic NSCLC Clinical Trial page.

Latest updates to the REGN 2810 vs Platinum Chemo in Metastatic NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe record history adds a 2026-05-08 entry with a new revision (v3.5.4) and flags that Quality Control has not concluded, while adding sections for Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and Document Section to the study record.SummaryDifference1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe record history indicates that results have been submitted for the study (transitioning from a state where no results were posted to one where results submission is recorded), alongside an updated site/application revision label.SummaryDifference0.2%

- Check46 days agoChange DetectedRevision history now shows an added v3.5.2 and a removed v3.5.0.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision v3.5.0 was added to the record history and revision v3.4.3 was removed.SummaryDifference0.1%

- Check81 days agoChange DetectedThe study record history was updated to add revision v3.4.3 and remove v3.4.2.SummaryDifference0.1%

- Check96 days agoChange DetectedThe Record History now includes dedicated sections for Study Status and Study Identification, expanding the visible history categories and clarifying updates to the trial's lifecycle.SummaryDifference0.4%

Stay in the know with updates to REGN 2810 vs Platinum Chemo in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN 2810 vs Platinum Chemo in Metastatic NSCLC Clinical Trial page.